Sarepta Therapeutics Inc (SRPT)
121.90
+1.24
(+1.03%)
USD |
NASDAQ |
Dec 24, 16:00
Sarepta Therapeutics Free Cash Flow: -480.40M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals Inc | -604.32M |
| Eli Lilly and Co | -2.275B |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Catalyst Pharmaceuticals Inc | 221.79M |
| Vertex Pharmaceuticals Inc | -1.352B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.70M |
| Cash from Investing (Quarterly) | -128.82M |
| Cash from Financing (Quarterly) | 13.76M |
| Free Cash Flow Per Share (Quarterly) | -1.075 |
| Free Cash Flow to Equity (Quarterly) | -109.21M |
| Free Cash Flow to Firm (Quarterly) | -107.96M |
| Free Cash Flow Yield | -3.92% |